Related Experiment Video
Updated: Oct 16, 2025

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Gastrointestinal Bleeding in Patients with SARS-CoV-2 Infection Managed by Interventional Radiology
Anna Maria Ierardi1, Andrea Coppola2, Silvia Tortora3
1Radiology Unit, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy.
Insights
Trans-arterial embolization (TAE) is a safe and effective treatment for gastrointestinal bleeding (GIB) in patients with Coronavirus Disease 2019 (COVID-19). This procedure demonstrated high technical and clinical success rates in the studied population.
Area of Science:
- Interventional Radiology
- Gastroenterology
- Infectious Diseases
Background:
- Gastrointestinal bleeding (GIB) is a serious complication in patients with Coronavirus Disease 2019 (COVID-19).
- Understanding patient characteristics and risk factors associated with GIB in COVID-19 is crucial for effective management.
Purpose of the Study:
- To evaluate the technical and clinical success of trans-arterial embolization (TAE) for treating GIB in COVID-19 patients.
- To assess the safety profile of TAE in this specific patient cohort.
- To describe the demographic and clinical characteristics of COVID-19 patients experiencing GIB.
Main Methods:
- Retrospective analysis of 34 hospitalized COVID-19 patients with GIB.
- Evaluation of patient risk factors, medications for COVID-19, and clinical/biological parameters.
- Analysis of intraprocedural data and embolization outcomes.
Main Results:
- GIB was more prevalent in males, with common comorbidities including overweight, hypertension, diabetes, and prior cardiac disease.
- Many patients had Acute Respiratory Distress Syndrome (ARDS) and elevated D-dimer levels.
- Trans-arterial embolization achieved high technical (88.2%) and clinical (94.1%) success rates with a low complication rate (5.9%).
Conclusions:
- Trans-arterial embolization is a feasible, effective, and safe therapeutic option for managing gastrointestinal bleeding in COVID-19 patients.
- The study identifies key characteristics of COVID-19 patients susceptible to GIB, aiding in early recognition and intervention.
Background:
This study was conducted to evaluate the technical and clinical success of trans-arterial embolization (TAE) as a treatment of gastrointestinal bleeding (GIB) in Coronavirus Disease 2019 (COVID-19) patients and to describe its safety; moreover, we describe the characteristics of these patients.
Methods:
Thirty-four COVID-19 hospitalized patients presented with GIB. Risk factors, drugs administered for COVID-19 infection, and clinical and biological parameters were evaluated. Furthermore, intraprocedural data and outcomes of embolization were analyzed.
Results:
GIB was more frequent in male. Overweight, hypertension, diabetes, previous cardiac disease, and anticoagulation preadmission (48.5%) were frequently found in our population. Previous or actual COVID Acute respiratory distress syndrome (ARDS) and a high level of D-dimer were encountered in most cases. Upper GIB was more frequent than lower GIB. Technical and clinical success rates of embolization were 88.2% and 94.1%, respectively. The complication rate was 5.9%.
Conclusions:
Our study highlights the most frequent characteristics of COVID-19 patients with GIB. Embolization is feasible, effective, and safe.
More Related Videos
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Esophageal Varices-I: Introduction
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...